Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical Models

Abstract excerpt

Glioblastoma (GBM) presents a significant public health challenge as the deadliest and most common malignant brain tumor in adults. Despite standard-of-care treatment, which includes surgery, radiation, and chemotherapy, mortality rates are high, underscoring the critical need for advancing GBM therapy. Over the past two decades, numerous clinical trials have been performed, yet only a small fraction demonstrated...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Brain Metastases and Treatment
• Share to Cancer Genomics and Diagnostics
• Share to Glioma Diagnosis and Treatment